98%
921
2 minutes
20
Purpose: This study aimed to investigate the genetic heterogeneity of primary monosymptomatic nocturnal enuresis (PMNE) and assess potential genetic variants contributing to its etiology.
Materials And Methods: A total of 92 children aged 5-15 years with a positive family history of PMNE were evaluated. All patients underwent detailed urological and nephrological assessments to exclude organic causes. Genetic testing was performed using high-resolution microarray technology to identify potential pathogenic variants.
Results: No pathogenic or likely pathogenic mutations were identified. A small number of patients exhibited variants of uncertain significance (VUS), none of which were conclusively linked to PMNE. Our findings challenge previous studies that reported significant genetic markers and highlight the complex genetic architecture of PMNE.
Conclusion: This study reinforces the genetic heterogeneity of PMNE and suggests it follows a polygenic and multifactorial inheritance pattern. Further research using whole-exome and whole-genome sequencing is needed to explore potential genetic contributors alongside environmental factors.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.22037/uj.v22i.8501 | DOI Listing |
Urol J
September 2025
Department of Child and Adolescent Psychiatry, Faculty of Medicine, Recep Tayyip Erdogan University, Rize, TURKIYE.
Purpose: This study aimed to investigate the genetic heterogeneity of primary monosymptomatic nocturnal enuresis (PMNE) and assess potential genetic variants contributing to its etiology.
Materials And Methods: A total of 92 children aged 5-15 years with a positive family history of PMNE were evaluated. All patients underwent detailed urological and nephrological assessments to exclude organic causes.
Objectives: To assess the predictive factors for relapse in pediatric patients with primary monosymptomatic nocturnal enuresis following the use desmopressin oral lyophilisate.
Methods: A prospective cohort study was conducted from 2018 to 2025. We evaluated whether patient age and gender, compliance, method of therapy discontinuation, and other parameters affected relapse occurrence.
J Pediatr Urol
July 2025
Malatya Turgut Özal University, Faculty of Medicine, Department of Pediatrics, Boran Mahallesi, Kırkgöz Caddesi No: 82B, Adres Kodu: 3712025703, Battalgazi, Malatya, Turkey. Electronic address:
Background: Primary monosymptomatic enuresis nocturna (PMNE) is a multifactorial disorder with possible neurological underpinnings. Micronutrient deficiencies, particularly vitamin B12, may affect urinary control mechanisms.
Objective: The aim of this study was to investigate the relationship between primary monosymptomatic nocturnal enuresis (PMNE) and serum vitamin B12 levels in children and to evaluate whether vitamin B12 deficiency is a potential risk factor for the development of enuresis.
BMC Urol
August 2025
Department of Pediatric Nephrology, Bahçeşehir University Medicine Faculty, Medicalpark Göztepe Hospital, Istanbul, Türkiye.
Background: Identifying clinical features that differentiate monosymptomatic nocturnal enuresis (MNE) from non-monosymptomatic nocturnal enuresis (NMNE) would aid in quick diagnosis, which would foster the introduction of early and appropriate therapeutic care options. The aim of this study is to determine whether patients with nocturnal enuresis have more daytime symptoms than reported in the literature.
Methods: In this retrospective study, patients aged 5-18 years who presented with complaints of nocturnal enuresis were evaluated.
Int Braz J Urol
June 2025
Departamento de Pediatria Unidade de Nefrologia Pediátrica, Faculdade de Medicina, Hospital das Clínicas, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, MG, Brasil.
Purpose: Approximately one-third of the children with primary monosymptomatic enuresis (PMNE) do not respond to first-line treatment. We aimed to investigate the short-term and six-month effectiveness of combining desmopressin acetate with parasacral transcutaneous electrical nerve stimulation (PTENS) in these children and adolescents.
Materials And Methods: Participants aged six-17 years with PMNE were randomly assigned to receive desmopressin acetate with active or sham PTENS.